Combivent Respimat Asthma Inhalers
May 13th, 2019
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat
May 13th, 2019
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat
November 14th, 2018
In October 2018, a motion to transfer multiple class-action lawsuits, as well as one individual action, regarding the generic medication
November 7th, 2018
ASA bans anti-vaccine group's Facebook ad for misleading parents on the dangers of vaccinating their children.
October 30th, 2018
In October 2018, a class-action lawsuit was filed against Westminster Pharmaceuticals and CVS Pharmacy for allegedly representing that its Thyroid
June 7th, 2018
December 2013: This case was voluntarily dismissed , the reasons for which have not been disclosed. October 2013: A class-action
June 7th, 2018
In September 2017, a class-action lawsuit was filed against Pfizer for allegedly misleadingly marketing Maximum Strength Robitussin Cough+Chest Congestion DM
June 6th, 2018
May 2016: The case was voluntarily dismissed , the reasons for which have not been disclosed. December 2013: The lawsuit
May 14th, 2018
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing
April 27th, 2018
April 2016: The Ninth Circuit Court of Appeals affirmed the dismissal concluding that the complaint failed to state a claim
April 27th, 2018
December 2013: This case was voluntarily dismissed , the reasons for which have not been disclosed. September 2013: A class-action
December 19th, 2017
November 2017: An arbitrator granted final approval of the settlement. August 2017: An arbitrator preliminarily approved a settlement agreement that
October 5th, 2017
February 2018: The Hammack appeal was dismissed for failure to prosecute. October 2017: The Sweeney appeal was dismissed for failure
September 27th, 2017
Online pharmacy selling injectable epinephrine attracts the attention of the FDA.
August 31st, 2017
In August 2017, a false advertising class-action lawsuit was filed against CVS. Among other things, plaintiffs allege that CVS deceptively
July 27th, 2017
January 2017: After a trial, judgment was entered in favor of the company because the plaintiff failed to prove that
July 6th, 2017
March 2015: This action was voluntarily dismissed , the reasons for which have not been disclosed. February 2015: A class-action
May 31st, 2017
November 2015: After plaintiffs filed an amended complaint making similar allegations, this action was voluntarily dismissed. The reasons for the
November 29th, 2016
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in
November 9th, 2016
In October 2016, a federal court dismissed a false advertising class-action lawsuit filed against Pfizer in 2015. The complaint had
August 2nd, 2016
April 2015: This action was dismissed . The reasons for the dismissal have not been disclosed. March 2015: A class-action